We agree with the need to reexamine the routine use of axillary dissection in the management of breast cancer patients, as advocated by Manjeet Chadha and Deborah Axelrod, in their article, "Is Axillary Dissection Always Indicated in Invasive
David W. Ollila, MD
Advertisement
Articles by David W. Ollila, MD
Advertisement
Latest Updated Articles
- Sentinel Lymphadenectomy: Accurate Histopathologic Staging of the Axilla
Published: July 1st 1998 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Nivolumab/Ipilimumab Improves Real-World Melanoma Outcomes Vs Pembrolizumab
2
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer
3
Neoadjuvant Cemiplimab/SBRT Yields Improved DFS in Resectable HCC
4
Novel Anti-CD5 Therapy Earns FDA RMAT Designation in T-Cell Lymphoma
5
